Vimarsana
Biggest News Aggregation in the World

Page 18 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

Bipolar disorder linked to early death more than smoking - Vimarsana News

Bipolar disorder linked to early death more than smoking

In two different groups, people with bipolar disorder were four to six times more likely as people without the condition to die prematurely, a study finds.

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments - Vimarsana News

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Phase 3 portion of Orbit Study and Phase 3 Cosmic Study of setrusumab for treatment of Osteogenesis Imperfecta conducted by partner Ultragenyx expected to complete enrollment around the end of 1Q...

SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung - Vimarsana News

SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced an

Residential addiction treatment for adolescen - Vimarsana News

Residential addiction treatment for adolescen

<p>Access to residential addiction treatment centers caring for U.S. adolescents under 18 years old in the United States is limited and costly, according to&nbsp;<a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2023.00777">a new study</a><u> supported by the National Institutes of Health</u>. Researchers found that only about half (54%) of the residential addiction treatment facilities that they contacted had a bed immediately available, and for those that had a waitlist, the average estimated time before a bed opened was 28 days. In additi...

SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung - Vimarsana News

SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced an